Reference
Gerard A, et al. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. Therapies : 7 May 2020. Available from: URL: https://doi.org/10.1016/j.therap.2020.05.002
Rights and permissions
About this article
Cite this article
Cardiac adverse reactions with off-label Covid-19 treatments. Reactions Weekly 1806, 10 (2020). https://doi.org/10.1007/s40278-020-79028-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79028-9